Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mouth Neoplasms | 2 | 2021 | 205 | 0.810 |
Why?
|
Antineoplastic Agents, Immunological | 2 | 2021 | 66 | 0.770 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2021 | 623 | 0.660 |
Why?
|
Glutathione | 4 | 2011 | 343 | 0.600 |
Why?
|
Colorectal Neoplasms | 3 | 2021 | 560 | 0.390 |
Why?
|
Proto-Oncogene Proteins c-pim-1 | 2 | 2015 | 87 | 0.250 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2021 | 14 | 0.210 |
Why?
|
B7-H1 Antigen | 1 | 2021 | 30 | 0.210 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2021 | 265 | 0.200 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2021 | 86 | 0.200 |
Why?
|
Protein Disulfide-Isomerases | 2 | 2011 | 27 | 0.190 |
Why?
|
PPAR delta | 1 | 2019 | 14 | 0.180 |
Why?
|
Dietary Fats | 1 | 2019 | 103 | 0.180 |
Why?
|
Hematopoietic Stem Cells | 2 | 2018 | 268 | 0.170 |
Why?
|
Dinoprostone | 1 | 2019 | 110 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 444 | 0.170 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 306 | 0.170 |
Why?
|
Dental Pulp | 1 | 2018 | 10 | 0.170 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 199 | 0.170 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 226 | 0.170 |
Why?
|
Periodontal Ligament | 1 | 2018 | 16 | 0.170 |
Why?
|
Immunotherapy | 1 | 2020 | 212 | 0.160 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 231 | 0.160 |
Why?
|
bcl-X Protein | 1 | 2017 | 36 | 0.160 |
Why?
|
Osteoblasts | 1 | 2018 | 99 | 0.160 |
Why?
|
Protein Kinase Inhibitors | 2 | 2017 | 331 | 0.160 |
Why?
|
Stomach Neoplasms | 1 | 2017 | 64 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 174 | 0.150 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 332 | 0.150 |
Why?
|
Osteogenesis | 1 | 2018 | 152 | 0.150 |
Why?
|
Neoplasms | 3 | 2015 | 1659 | 0.150 |
Why?
|
Circadian Rhythm | 2 | 2008 | 218 | 0.140 |
Why?
|
Signal Transduction | 4 | 2014 | 2686 | 0.130 |
Why?
|
Neoplasms, Experimental | 1 | 2015 | 118 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2015 | 135 | 0.130 |
Why?
|
MicroRNAs | 1 | 2019 | 447 | 0.130 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2014 | 11 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 467 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2014 | 33 | 0.120 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 183 | 0.120 |
Why?
|
Hepatocyte Growth Factor | 1 | 2014 | 63 | 0.120 |
Why?
|
Animals | 10 | 2021 | 20849 | 0.120 |
Why?
|
Cell Differentiation | 1 | 2018 | 1034 | 0.120 |
Why?
|
Tumor Microenvironment | 1 | 2015 | 211 | 0.120 |
Why?
|
Mice | 8 | 2021 | 8461 | 0.110 |
Why?
|
Cell Line, Tumor | 5 | 2017 | 1848 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2019 | 304 | 0.110 |
Why?
|
Humans | 14 | 2021 | 68504 | 0.110 |
Why?
|
Protein Processing, Post-Translational | 2 | 2011 | 284 | 0.110 |
Why?
|
Reactive Nitrogen Species | 1 | 2011 | 32 | 0.100 |
Why?
|
Glutathione Transferase | 1 | 2011 | 166 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2011 | 142 | 0.090 |
Why?
|
Fibroblasts | 1 | 2015 | 902 | 0.090 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 2789 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2011 | 215 | 0.090 |
Why?
|
beta-Transducin Repeat-Containing Proteins | 1 | 2008 | 2 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 756 | 0.090 |
Why?
|
beta Catenin | 1 | 2008 | 73 | 0.080 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 499 | 0.080 |
Why?
|
Lung Neoplasms | 1 | 2017 | 1172 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2008 | 219 | 0.080 |
Why?
|
Trans-Activators | 1 | 2008 | 237 | 0.080 |
Why?
|
Aged | 2 | 2021 | 14841 | 0.080 |
Why?
|
Nitric Oxide | 1 | 2009 | 382 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2008 | 268 | 0.080 |
Why?
|
Cell Cycle Proteins | 1 | 2008 | 229 | 0.070 |
Why?
|
Mice, Nude | 2 | 2017 | 294 | 0.070 |
Why?
|
Up-Regulation | 2 | 2019 | 682 | 0.070 |
Why?
|
Male | 4 | 2021 | 37265 | 0.070 |
Why?
|
Cyclin E | 1 | 2005 | 19 | 0.070 |
Why?
|
Middle Aged | 2 | 2021 | 21115 | 0.070 |
Why?
|
HCT116 Cells | 2 | 2019 | 63 | 0.070 |
Why?
|
Female | 5 | 2021 | 38003 | 0.070 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2005 | 44 | 0.070 |
Why?
|
Transcription Factors | 1 | 2008 | 751 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2017 | 331 | 0.060 |
Why?
|
RNA, Small Interfering | 2 | 2015 | 434 | 0.060 |
Why?
|
HT29 Cells | 1 | 2021 | 42 | 0.050 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 104 | 0.050 |
Why?
|
Tumor Escape | 1 | 2021 | 37 | 0.050 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 196 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2005 | 1172 | 0.050 |
Why?
|
HEK293 Cells | 1 | 2021 | 325 | 0.050 |
Why?
|
Cysteine | 2 | 2011 | 112 | 0.050 |
Why?
|
Cyclooxygenase 1 | 1 | 2019 | 29 | 0.050 |
Why?
|
Survival Analysis | 1 | 2021 | 714 | 0.050 |
Why?
|
Nanog Homeobox Protein | 1 | 2019 | 6 | 0.050 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2019 | 37 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2018 | 2668 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2019 | 166 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 138 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2021 | 798 | 0.040 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 160 | 0.040 |
Why?
|
Diet, High-Fat | 1 | 2019 | 81 | 0.040 |
Why?
|
Thiazoles | 1 | 2019 | 95 | 0.040 |
Why?
|
RNA, Long Noncoding | 1 | 2019 | 54 | 0.040 |
Why?
|
Neoplastic Stem Cells | 1 | 2019 | 84 | 0.040 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 851 | 0.040 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 200 | 0.040 |
Why?
|
Aniline Compounds | 1 | 2017 | 52 | 0.040 |
Why?
|
Drug Synergism | 1 | 2017 | 260 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 613 | 0.040 |
Why?
|
Sulfonamides | 1 | 2017 | 141 | 0.040 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 170 | 0.040 |
Why?
|
MAP Kinase Signaling System | 1 | 2017 | 247 | 0.040 |
Why?
|
Random Allocation | 1 | 2017 | 442 | 0.040 |
Why?
|
Umbilical Veins | 1 | 2015 | 54 | 0.030 |
Why?
|
Immunoblotting | 1 | 2015 | 252 | 0.030 |
Why?
|
Cohort Studies | 1 | 2021 | 2356 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2018 | 1031 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2015 | 209 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 282 | 0.030 |
Why?
|
Eukaryotic Initiation Factor-3 | 1 | 2014 | 5 | 0.030 |
Why?
|
Thiazolidines | 1 | 2014 | 23 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2015 | 489 | 0.030 |
Why?
|
Transfection | 1 | 2015 | 776 | 0.030 |
Why?
|
HeLa Cells | 1 | 2014 | 237 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 507 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2014 | 178 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 710 | 0.030 |
Why?
|
Biphenyl Compounds | 1 | 2014 | 184 | 0.030 |
Why?
|
RNA Interference | 1 | 2014 | 266 | 0.030 |
Why?
|
Blotting, Western | 1 | 2015 | 953 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 369 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2015 | 1174 | 0.030 |
Why?
|
Cell Movement | 1 | 2014 | 630 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2011 | 50 | 0.030 |
Why?
|
Protein Binding | 1 | 2014 | 1024 | 0.030 |
Why?
|
Phosphorylation | 1 | 2014 | 1197 | 0.030 |
Why?
|
Ligands | 1 | 2011 | 317 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2009 | 50 | 0.020 |
Why?
|
4-Aminobenzoic Acid | 1 | 2009 | 30 | 0.020 |
Why?
|
para-Aminobenzoates | 1 | 2009 | 27 | 0.020 |
Why?
|
Azo Compounds | 1 | 2009 | 33 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2014 | 1692 | 0.020 |
Why?
|
Protein Folding | 1 | 2009 | 82 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2021 | 7026 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2009 | 99 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 566 | 0.020 |
Why?
|
CLOCK Proteins | 1 | 2008 | 7 | 0.020 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2008 | 26 | 0.020 |
Why?
|
Period Circadian Proteins | 1 | 2008 | 16 | 0.020 |
Why?
|
Protein Stability | 1 | 2008 | 89 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2009 | 419 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 306 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 1070 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2009 | 267 | 0.020 |
Why?
|
Models, Molecular | 1 | 2009 | 546 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2015 | 2548 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2009 | 1080 | 0.020 |
Why?
|
Proteomics | 1 | 2009 | 246 | 0.020 |
Why?
|
Down-Regulation | 1 | 2008 | 447 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2009 | 1442 | 0.020 |
Why?
|
Proteins | 1 | 2011 | 472 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2011 | 718 | 0.020 |
Why?
|
Photoperiod | 1 | 2005 | 11 | 0.020 |
Why?
|
Mitotic Index | 1 | 2005 | 14 | 0.020 |
Why?
|
Motor Activity | 1 | 2008 | 621 | 0.020 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2005 | 114 | 0.020 |
Why?
|
Locomotion | 1 | 2005 | 135 | 0.020 |
Why?
|
DNA | 1 | 2005 | 592 | 0.010 |
Why?
|
Liver | 1 | 2005 | 1109 | 0.010 |
Why?
|